Related Experiment Video
Updated: Oct 15, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53
Alyssa M Klein1,2, Lynn Biderman1, David Tong1
1Department of Biological Sciences, Columbia University, New York, NY 10027.
Abstract:
The p53 tumor suppressor protein, known to be critically important in several processes including cell-cycle arrest and apoptosis, is highly regulated by multiple mechanisms, most certifiably the Murine Double Minute 2-Murine Double Minute X (MDM2-MDMX) heterodimer. The role of MDM2-MDMX in cell-cycle regulation through inhibition of p53 has been well established. Here we report that in cells either lacking p53 or expressing certain tumor-derived mutant forms of p53, loss of endogenous MDM2 or MDMX, or inhibition of E3 ligase activity of the heterocomplex, causes cell-cycle arrest. This arrest is correlated with a reduction in E2F1, E2F3, and p73 levels. Remarkably, direct ablation of endogenous p73 produces a similar effect on the cell cycle and the expression of certain E2F family members at both protein and messenger RNA levels. These data suggest that MDM2 and MDMX, working at least in part as a heterocomplex, may play a p53-independent role in maintaining cell-cycle progression by promoting the activity of E2F family members as well as p73, making them a potential target of interest in cancers lacking wild-type p53.
Insights
The Murine Double Minute 2-Murine Double Double Minute X (MDM2-MDMX) complex regulates cell-cycle progression independently of p53. Inhibiting MDM2-MDMX or p73 causes cell-cycle arrest, suggesting new cancer targets.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- The p53 tumor suppressor protein is crucial for cell-cycle arrest and apoptosis.
- The Murine Double Minute 2-Murine Double Minute X (MDM2-MDMX) heterodimer is a key regulator of p53.
- MDM2-MDMX's role in p53-mediated cell-cycle regulation is well-established.
Purpose of the Study:
- To investigate the p53-independent functions of the MDM2-MDMX complex.
- To explore the role of MDM2-MDMX in cell-cycle progression in the absence of functional p53.
- To identify potential therapeutic targets in cancers with non-wild-type p53.
Main Methods:
- Studied cells lacking p53 or expressing mutant p53.
- Assessed the effects of MDM2/MDMX loss or E3 ligase inhibition on cell-cycle arrest.
- Analyzed the impact on E2F1, E2F3, and p73 protein and mRNA levels.
- Investigated the consequences of p73 ablation on cell-cycle progression and E2F expression.
Main Results:
- Loss of MDM2/MDMX or inhibition of their E3 ligase activity induced cell-cycle arrest in p53-deficient or mutant cells.
- This arrest correlated with reduced levels of E2F1, E2F3, and p73.
- Directly ablating p73 mimicked these effects on the cell cycle and E2F family member expression.
- MDM2-MDMX appears to promote E2F family member and p73 activity in a p53-independent manner.
Conclusions:
- The MDM2-MDMX complex plays a significant p53-independent role in maintaining cell-cycle progression.
- This function involves promoting the activity of E2F family members and p73.
- MDM2-MDMX represents a potential therapeutic target in cancers lacking wild-type p53.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

